Martin Kaloostian
Papers
1
Total Citations
115
H-Index
1
About
Martin Kaloostian is a leading figure in bioanalytical chemistry, with a primary focus on the development of advanced chromatographic methods for therapeutic drug monitoring. His most influential work centers on the quantification of immunosuppressants, particularly mycophenolic acid (MPA) and its major metabolite, the glucuronide conjugate. In his landmark 1996 study, cited over 115 times, Kaloostian pioneered both manual and automated robotic high-performance liquid chromatography (HPLC) techniques for analyzing these compounds in human plasma. This dual approach not only provided robust, validated methods for clinical labs but also demonstrated the feasibility of automation in complex bioanalysis, significantly improving throughput and reproducibility. His contributions have been instrumental in enabling precise dosing of mycophenolate mofetil in transplant patients, directly impacting patient care. By bridging the gap between manual method development and robotic automation, Kaloostian’s work remains a foundational reference for researchers and pharmaceutical scientists seeking efficient, reliable analytical solutions for immunosuppressive drug monitoring.
Research Focus
Key Achievements
Top Papers
- 1